BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3919550)

  • 1. Hemodynamic effects of molsidomine in patients with acute myocardial infarction.
    Reifart N; Neidl K; Kaltenbach M; Bussmann WD
    Am Heart J; 1985 Mar; 109(3 Pt 2):708-12. PubMed ID: 3919550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
    Bussmann WD; Neidl K; Kaltenbach M
    Klin Wochenschr; 1982 Jan; 60(2):77-85. PubMed ID: 6896077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
    Cantelli I; Lolli C; Brunelli A; Bracchetti D
    Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.
    Renard M; Jacobs P; Liebens I; Friart A; Bernard R
    Am Heart J; 1985 Mar; 109(3 Pt 2):720-2. PubMed ID: 3919551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
    Larbig DT; Milstrey HR; Nasse H; Kahle T
    Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molsidomine in the treatment of acute heart failure.
    Drajer S; Vazquez A; Cercós H; Torres H; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
    Am Heart J; 1985 Mar; 109(3 Pt 2):712-5. PubMed ID: 3838409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.
    Acar J; Kulas A; Escudier B
    Am Heart J; 1985 Mar; 109(3 Pt 2):685-7. PubMed ID: 3883737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.
    Aptecar M; Otero y Garzon CA; Vasquez A; Varini S; Collia L; Esteguy A; Caruso S
    Am Heart J; 1981 Apr; 101(4):369-73. PubMed ID: 6894215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of molsidomine and dopamine infusion on the size of canine experimental myocardial infarct.
    Fiedler VB; Buchheim S; Göbel H; Nitz RE
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):314-20. PubMed ID: 6897743
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
    Rudolph W; Dirschinger J
    Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of molsidomine on left ventricular dimensions and cardiac function in patients with chronic heart failure.
    Berkenboom GM; Sobolski JC; Vandermoten PP; Stoupel EE; Degre SG
    Am Heart J; 1985 Mar; 109(3 Pt 2):691-3. PubMed ID: 3838405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of the preparation korvatone].
    Charchoglian RA; Esin NN; Belozerov GE
    Sov Med; 1982; (5):15-8. PubMed ID: 7051350
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of oral molsidomine effects on ventricular function and dimensions in the conscious dog.
    Fiedler VB; Göbel H; Nitz RE
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):56-75. PubMed ID: 6409016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
    Schartl M; Dougherty C; Rutsch W; Schmutzler H
    Am Heart J; 1985 Mar; 109(3 Pt 2):649-53. PubMed ID: 3838401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined digoxin-molsidomine therapy in congestive heart failure following acute myocardial infarction.
    Cantelli I; Parchi C; Palmieri M; Brunelli A; Sangiorgio P; Bracchetti D
    J Cardiovasc Pharmacol; 1986; 8(3):491-9. PubMed ID: 2425163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of molsidomine in experimental models of ischemic cardiac disease.
    Nitz RE; Martorana PA
    Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction.
    Drajer S; Cercós H; Torres H; Vazquez A; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
    Eur J Clin Pharmacol; 1984; 27(4):419-22. PubMed ID: 6549166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.